InvestorsHub Logo
icon url

ss0722

05/06/20 10:56 PM

#2155 RE: tim00mike #2154

Just substitute KNWN for DCOM in that article : "DexCom, Inc. is a medical device manufacturer that makes continuous blood glucose monitoring devices for patients with diabetes. We believe that DexCom’s device is a superior method for monitoring blood sugar compared with finger sticks (the traditional method). We also believe that DexCom’s market opportunity is large–its core market consists of the 3.2 million insulin intensive patients in the U.S. plus another 3 million to 5 million insulin intensives outside the U.S. The company’s stock rose after it reported significantly higher sales and profits in the fourth quarter of 2019, driven by strong demand for the company's G6 device. Although we think DexCom's growth may be moderately impacted in the near term by the COVID-19 pandemic, we continue to believe the company has a long runway for growth."
icon url

ss0722

05/06/20 11:03 PM

#2156 RE: tim00mike #2154

But what if KNWN starts to steal market share from DCOM, isn't dexcom going to try and snuff KNWN out? And wonder if DCOM is even aware of KNWN yet? They are not going to like some little unknown company taking intruding on their turf, the David Goliath scenario...